Definition of yttrium Y 90 DOTA-tyr3-octreotide - NCI Dictionary of Cancer Terms

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate NCI Responds to Hurricanes The Nation's Investment in Cancer Research FY 2009 Cancer Trends Progress Report: 2007 Update Past Highlights

You CAN Quit Smoking Now!

Search for

Starts with

Contains

In English En español

yttrium Y 90 DOTA-tyr3-octreotide (IH-tree-um ... OK-tree-oh-tide)

A substance being studied in the treatment of some types of cancer. Yttrium Y 90 DOTA-tyr3-octreotide contains yttrium Y 90 (a radioactive form of the metal yttrium) attached to a molecule that binds to certain types of neuroendocrine tumors (tumors that come from cells that release hormones). The radioactivity from yttrium Y 90 may kill the cancer cells. Also called yttrium Y 90 edotreotide and yttrium Y 90 SMT 487.

Previous Definitions:	yttrium, yttrium Y 90, yttrium Y 90 DOTA monoclonal antibody HuPAM4, yttrium Y 90 DOTA monoclonal antibody HuAFP31, yttrium Y 90 DOTA-biotin
Next Definitions:	yttrium Y 90 edotreotide, yttrium Y 90 ibritumomab tiuxetan, yttrium Y 90 SMT 487, Zactima, Zarnestra